CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 25.80
-1.04 (-3.87%)
Sep 11, 2026, 4:08 PM HKT
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 11.88 billion as of September 11, 2026. Its market cap has decreased by -32.26% in one year.
Market Cap
11.88B
Enterprise Value
10.83B
Revenue
1.43B
Ranking
n/a
PE Ratio
253.26
Stock Price
25.80
ChartMarket Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 11.88B, an increase of 56.92%. That is a compound annual growth rate of 6.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 11.88B | -5.94% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sunshine Lake Pharma | 21.29B |
| Grand Pharmaceutical Group | 16.93B |
| The United Laboratories International Holdings | 16.05B |
| Fujian Haixi Pharmaceuticals | 15.14B |
| Ab&B Bio-Tech CO., LTD. JS | 11.54B |
| Consun Pharmaceutical Group | 11.04B |
| Shandong Xinhua Pharmaceutical Company | 8.95B |
| SSY Group | 7.79B |